Navigation Links
LSTM to lead EU project to coordinate antimalarial drug research

The European Commission is funding a two year, 500,000 project to co-ordinate European and international research into the development of new drugs to treat malaria.

The CRIMALDDI project (Coordination, Rationalisation and Integration of Antimalarial Drug Discovery and Development Initiatives) is being led by the Liverpool School of Tropical Medicine (LSTM) and brings together key players in the antimalarial drug discovery fields including the World Health Organisation, the Medicines for Malaria Venture (MMV) and leading research organisations across Europe.

Professor Steve Ward, Deputy Director of LSTM and Scientific Coordinator of the CRIMALDDI project explained: "New drugs to prevent, treat and eventually eliminate malaria are desperately needed if we are to make an impact upon the millions needlessly dying from this disease each year. Antimalarial drug research and development (R&D) programmes are in operation across Europe and throughout the world, but too often these initiatives are uncoordinated and time and money is spent going over old ground."

CRIMALDDI will address this by assessing research in Europe and internationally. It will develop a prioritised roadmap for antimalarial drug discovery efforts in Europe and a 5-year action plan to deliver on this roadmap. An expert advisory group will provide external validation and ensure that the plans are practical and appropriate. CRIMALDDI will also seek to formulate strategies to ensure better co-ordination of R&D, remove barriers to drug development and facilitate the dissemination of results.

Tim Wells, CSO for MMV said "CRIMALDDI is a timely initiative. It makes a great deal of sense to coordinate efforts globally so that researchers know exactly what is going on in this field and do not run the risk of duplicating efforts. With limited resources available for antimalarial drug R&D, time, funding and expertise are too precious to waste."

Commenting on the project, Professor Ward said: "Co-ordinating research will mean that resources are better directed towards the faster development of new drugs to treat and eliminate malaria. We will look at the global status of antimalarial drug discovery and use that information to ensure that the research agenda for antimalarials in Europe over the next decade is properly aligned with what's going on elsewhere in the world."


Contact: Alan Hughes
Liverpool School of Tropical Medicine

Related medicine news :

1. QI projects may -- or may not -- improve patient safety and outcomes
2. MU researchers to collaborate on $20 million project
3. Fry Construction Selected for High-Profile Medical Imaging Project
4. Jacobs Receives Contract for New Hospital Project in Belgium
5. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
6. Global Health Project targets reducing AIDS among Indias adolescents
7. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio
8. New Business Development of Multi-Hospital Project!
9. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
10. Meth Project Advertisements Selected for National Prevention Campaign
11. Pillow, PAs Great American Sleep Better(TM)Project Reports Results
Post Your Comments:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
Breaking Medicine Technology: